Call for abstracts and a heartfelt farewell

Hypertension Canada eINFO - April 2015

Greetings!

Abstracts are now being accepted for the 2015 Canadian Hypertension Congress! Mark your calendar and join us October 22-24. Also, don't miss a heartfelt farewell to a hypertension hero.

Canadian Hypertension Congress 2015

A call for abstracts is now open. Registration begins May 1.

Join us October 22-24 in Toronto for the 5th Annual Canadian Hypertension Congress (CHC) . The CHC gathers key opinion leaders and showcases the latest research in hypertension. It is the only Canadian congress designed specifically to enable the development and exchange of evidence-based information on the pathobiology and management of hypertension. Our Primary Care Day on Friday, October 23 provides the latest updates on hypertension management and control for general practitioners, nurses, pharmacists and other health care professionals.

An Unsung Hypertension Hero Retires

a tribute by Dr. Norman Campbell

On April 8th, 2015, Lianne Vardy will retire from the Public Health Agency of Canada (PHAC). Collaboration between PHAC and Hypertension Canada is a critical component of our success in measuring and improving health outcomes. Lianne's passion and team spirit are second to none. Read a full farewell here.

Happy retirement, Lianne, you have left a great legacy!

Know Your Numbers

World Hypertension Day is May 14, 2015

Throughout May, Hypertension Canada will promote World Hypertension Day, an initiative by the World Hypertension League to encourage the prevention and control of this silent killer. Our campaign will include a social and traditional media campaign, with support from our corporate partners Servier Canada and Zona Health. Follow us on Twitter @HTNCanada today!

Looking for ideas to promote World Hypertension Day in your community? Take inspiration from the great ideas around the globe.

Did you miss our World Salt Awareness Week campaign? Check it out here!

Member Publication of the Month

The Cardiovascular Safety of Sulfonylureas: More than Forty Years of Continuous Controversy without an Answer.
Abdelmoneim AS, Eurich DT, Light PE, Senior PA, Seubert JM, Makowsky MJ, Simpson SH.

Diabetes Obes Metab. 2015 Feb 25. doi: 10.1111/dom.12456

MID: 25711240The Cardiovascular Safety of Sulfonylureas: More than Forty Years of Continuous Controversy without an Answer.

The full PubMed report is also available in English and French.

"The Interdisciplinary Management of Hypertensive Patients"
for all healthcare professionals (15.5 credits)

Download and Order
Educational Resources

Global Hypertension
Events Calendar

Thanks for readingGreetings! . Please stay in touch and don't forget to share!